These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 21988306)
41. Clinical development of placental malaria vaccines and immunoassays harmonization: a workshop report. ChĂȘne A; Houard S; Nielsen MA; Hundt S; D'Alessio F; Sirima SB; Luty AJ; Duffy P; Leroy O; Gamain B; Viebig NK Malar J; 2016 Sep; 15():476. PubMed ID: 27639691 [TBL] [Abstract][Full Text] [Related]
42. Predicting the cost-effectiveness of introducing a pre-erythrocytic malaria vaccine into the expanded program on immunization in Tanzania. Tediosi F; Hutton G; Maire N; Smith TA; Ross A; Tanner M Am J Trop Med Hyg; 2006 Aug; 75(2 Suppl):131-43. PubMed ID: 16931824 [TBL] [Abstract][Full Text] [Related]
47. Severe Plasmodium falciparum malaria in a non-immune pregnant woman. Bukman A; Weinans MJ; van Loon AJ Int J Gynaecol Obstet; 1997 Nov; 59(2):143-4. PubMed ID: 9431879 [No Abstract] [Full Text] [Related]
48. Malaria vaccine difficult to roll out because four doses are needed, WHO says. Gulland A BMJ; 2015 Oct; 351():h5706. PubMed ID: 26502887 [No Abstract] [Full Text] [Related]
49. Evaluating the efficacy of a malaria vaccine. Small DS; Cheng J; Ten Have TR Int J Biostat; 2010 Feb; 6(2):Article 4. PubMed ID: 20405046 [TBL] [Abstract][Full Text] [Related]
50. Falciparum malaria in pregnancy. McGready R; Nosten F Aust N Z J Obstet Gynaecol; 1995 Nov; 35(4):468-9. PubMed ID: 8717584 [No Abstract] [Full Text] [Related]
51. Accelerator or Brake: Immune Regulators in Malaria. Cai C; Hu Z; Yu X Front Cell Infect Microbiol; 2020; 10():610121. PubMed ID: 33363057 [TBL] [Abstract][Full Text] [Related]
52. Editorial: Immunity to Parasitic Infections in Pregnancy. Doritchamou JYA; Aitken EH; Luty AJF Front Immunol; 2021; 12():813446. PubMed ID: 34975925 [No Abstract] [Full Text] [Related]
53. The impact of Plasmodium-driven immunoregulatory networks on immunity to malaria. Boyle MJ; Engwerda CR; Jagannathan P Nat Rev Immunol; 2024 Jun; ():. PubMed ID: 38862638 [TBL] [Abstract][Full Text] [Related]
54. The pathology of malaria: a possible target for immunisation? Playfair JH Immunol Lett; 1994 Dec; 43(1-2):83-6. PubMed ID: 7737694 [No Abstract] [Full Text] [Related]
55. The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections. You H; Jones MK; Gordon CA; Arganda AE; Cai P; Al-Wassiti H; Pouton CW; McManus DP Clin Microbiol Rev; 2023 Mar; 36(1):e0024121. PubMed ID: 36625671 [TBL] [Abstract][Full Text] [Related]
56. Progress towards vaccines to protect pregnant women from malaria. Rogerson SJ; Aitken EH EBioMedicine; 2019 Apr; 42():12-13. PubMed ID: 30904605 [No Abstract] [Full Text] [Related]
57. Re: Musings on malaria morbidity and mortality after the new Mosquirix Asante KP; Malm K; Darko DM; Koram KA Ghana Med J; 2019 Sep; 53(3):252-253. PubMed ID: 31741498 [No Abstract] [Full Text] [Related]
58. How parasites evade the immune response. Cox FE Immunol Today; 1984 Feb; 5(2):29-33. PubMed ID: 25291365 [TBL] [Abstract][Full Text] [Related]
59. Questioning effectiveness of vaccines against malaria. Raoult D Lancet Infect Dis; 2017 Jan; 17(1):22. PubMed ID: 27998566 [No Abstract] [Full Text] [Related]